Literature DB >> 21080802

Potential role of miRNAs and their inhibitors in glioma treatment.

Kaveh Asadi-Moghaddam1, E Antonio Chiocca, Sean E Lawler.   

Abstract

Recent years have seen an intense period of research on the functions of miRNAs, recently discovered key regulators of gene expression that act through suppression of translation of target mRNAs. Several hundred miRNAs have been identified in humans, and these show characteristic expression patterns, depending on tissue type, cell type or environmental stimuli. Like other types of cancer, the brain tumor glioblastoma shows a distinct miRNA expression signature, and a number of recent studies have linked these miRNA alterations to key hallmarks of glioblastoma including proliferation, survival, invasion, angiogenesis and stem cell-like behavior. These studies have opened the door to the possibility of utilizing miRNAs or miRNA antagonists as therapeutic agents for the treatment of brain tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080802      PMCID: PMC7330712          DOI: 10.1586/era.10.168

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  64 in total

1.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain.

Authors:  Peter T Nelson; Don A Baldwin; Wigard P Kloosterman; Sakari Kauppinen; Ronald H A Plasterk; Zissimos Mourelatos
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

Review 2.  Genetic strategies for brain tumor therapy.

Authors:  S E Lawler; P P Peruzzi; E A Chiocca
Journal:  Cancer Gene Ther       Date:  2006-03       Impact factor: 5.987

3.  MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.

Authors:  Jakub Godlewski; Michal O Nowicki; Agnieszka Bronisz; Gerard Nuovo; Jeff Palatini; Michael De Lay; James Van Brocklyn; Michael C Ostrowski; E Antonio Chiocca; Sean E Lawler
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

4.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

5.  MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a.

Authors:  Yu Zhang; Tengfei Chao; Ran Li; Wei Liu; Yang Chen; Xingqi Yan; Yanhua Gong; Bin Yin; Wei Liu; Boqing Qiang; Jizhong Zhao; Jiangang Yuan; Xiaozhong Peng
Journal:  J Mol Med (Berl)       Date:  2008-09-23       Impact factor: 4.599

6.  MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.

Authors:  Yunqing Li; Fadila Guessous; Ying Zhang; Charles Dipierro; Benjamin Kefas; Elizabeth Johnson; Lukasz Marcinkiewicz; Jinmai Jiang; Yanzhi Yang; Thomas D Schmittgen; Beatriz Lopes; David Schiff; Benjamin Purow; Roger Abounader
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

7.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.

Authors:  M Crawford; E Brawner; K Batte; L Yu; M G Hunter; G A Otterson; G Nuovo; C B Marsh; S P Nana-Sinkam
Journal:  Biochem Biophys Res Commun       Date:  2008-07-03       Impact factor: 3.575

8.  MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.

Authors:  Hong-Fei Xia; Tian-Zhu He; Chun-Mei Liu; Yi Cui; Pei-Pei Song; Xiao-Hua Jin; Xu Ma
Journal:  Cell Physiol Biochem       Date:  2009-05-06

9.  Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.

Authors:  Carlos le Sage; Remco Nagel; David A Egan; Mariette Schrier; Elly Mesman; Annunziato Mangiola; Corrado Anile; Giulio Maira; Neri Mercatelli; Silvia Anna Ciafrè; Maria Giulia Farace; Reuven Agami
Journal:  EMBO J       Date:  2007-07-12       Impact factor: 11.598

Review 10.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

View more
  11 in total

Review 1.  Integration and analysis of genome-scale data from gliomas.

Authors:  Gregory Riddick; Howard A Fine
Journal:  Nat Rev Neurol       Date:  2011-07-05       Impact factor: 42.937

2.  High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype.

Authors:  Yi Pu; Shouwei Li; Chuanbao Zhang; Zhaoshi Bao; Zhengxiang Yang; Lihua Sun
Journal:  J Neurooncol       Date:  2014-12-20       Impact factor: 4.130

3.  miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.

Authors:  Krishan Jethwa; Jun Wei; Kayla McEnery; Amy B Heimberger
Journal:  Clin Investig (Lond)       Date:  2011-12

4.  Direct quantification of microRNA at low picomolar level in sera of glioma patients using a competitive hybridization followed by amplified voltammetric detection.

Authors:  Jianxiu Wang; Xinyao Yi; Hailin Tang; Hongxing Han; Minghua Wu; Feimeng Zhou
Journal:  Anal Chem       Date:  2012-07-10       Impact factor: 6.986

5.  MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.

Authors:  Alfredo Conti; Sara G Romeo; Annamaria Cama; Domenico La Torre; Valeria Barresi; Gaetana Pezzino; Chiara Tomasello; Salvatore Cardali; Filippo F Angileri; Francesca Polito; Guido Ferlazzo; Rosamaria Di Giorgio; Antonino Germanò; M'hammed Aguennouz
Journal:  Tumour Biol       Date:  2016-08-06

6.  MiRNA expression patterns predict survival in glioblastoma.

Authors:  Maximilian Niyazi; Franz Zehentmayr; Olivier M Niemöller; Sabina Eigenbrod; Hans Kretzschmar; Klaus Schulze-Osthoff; Jörg-Christian Tonn; Mike Atkinson; Simone Mörtl; Claus Belka
Journal:  Radiat Oncol       Date:  2011-11-10       Impact factor: 3.481

Review 7.  Recent advances in the molecular understanding of glioblastoma.

Authors:  Fonnet E Bleeker; Remco J Molenaar; Sieger Leenstra
Journal:  J Neurooncol       Date:  2012-01-20       Impact factor: 4.130

8.  Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells.

Authors:  Ming-Fei Lang; Su Yang; Chunnian Zhao; Guoqiang Sun; Kiyohito Murai; Xiwei Wu; Jinhui Wang; Hanlin Gao; Christine E Brown; Xiaoxuan Liu; Jiehua Zhou; Ling Peng; John J Rossi; Yanhong Shi
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

9.  miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.

Authors:  Joseph C Loftus; Julianna T D Ross; Kimberly M Paquette; Vincent M Paulino; Sara Nasser; Zhongbo Yang; Jean Kloss; Seungchan Kim; Michael E Berens; Nhan L Tran
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

Review 10.  Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas.

Authors:  Patrick-Denis St-Coeur; Mohamed Touaibia; Miroslava Cuperlovic-Culf; Pier Morin
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-06-01       Impact factor: 7.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.